Look for:

Our offer for

MARINOMED BIOTECH AG


ISIN:
ATMARINOMED6
WKN:
-
2022/09/30 11:32:34
Price
60.00 EUR
Difference 0.00% (0.00)

General attributes

ISINATMARINOMED6
SymbolMARI
ExchangeVienna Stock Exchange
CurrencyEUR
SectorOther
Security typeStock
Market cap (m)90 EUR
BenchmarkATX AUSTRIAN TRADED INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open59.00 EUR
High60.00 EUR
Low58.40 EUR
Close (prev. day)60.00 EUR
VWAP59.661539 EUR
Volume (pcs)260
Trading volume15,512.00
Number of trades7
Last size50

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: MARINOMED BIOTECH AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/09/30 11:32:34
Price
60.00 EUR
Difference 0.00% (0.00)

General attributes

ISINATMARINOMED6
SymbolMARI
ExchangeVienna Stock Exchange
CurrencyEUR
SectorOther
Security typeStock
Market cap (m)90 EUR
BenchmarkATX AUSTRIAN TRADED INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open59.00 EUR
High60.00 EUR
Low58.40 EUR
Close (prev. day)60.00 EUR
VWAP59.661539 EUR
Volume (pcs)260
Trading volume15,512.00
Number of trades7
Last size50

Performance and Risk

6M1Y3Y
Perf (%)-24.62%-48.72%-40.00%
Perf (abs.)-19.60-57.00-40.00
Beta0.270.370.25
Volatility33.3836.2633.65
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)59.48 EUR (416)
Ø price 30 days | Ø volume 30 days (pcs.)61.03 EUR (454)
Ø price 100 days | Ø volume 100 days (pcs.)65.96 EUR (545)
Ø price 250 days | Ø volume 250 days (pcs.)81.15 EUR (972)
YTD High | date99.80 EUR (2022/01/19)
YTD Low | date57.00 EUR (2022/09/28)
52 Weeks High | date115.00 EUR (2021/10/01)
52 Weeks Low | date57.00 EUR (2022/09/28)

All listings for MARINOMED BIOTECH AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2022/09/3011:3260.00 EUR0.027
Tradegate2022/09/2922:0260.20 EUR0.001
Stuttgart2022/09/3014:3258.60 EUR0.009
Munich2022/09/3008:0359.20 EUR0.001
Frankfurt2022/09/3008:0258.60 EUR0.001
Duesseldorf2022/09/3018:3058.40 EUR0.0012
Berlin2022/09/3018:4759.40 EUR0.0013

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=141937&ID_TYPE_IMAGE_LOGO=2

Contact Details

MARINOMED BIOTECH AG
- -
Hovengasse 25 - 2100 Korneuburg
Telefon: 43-1-2262-90300
Fax: 43-1-25077-4493
E-mail: office@marinomed.com

PDF Downloads

Annual report: MARINOMED BIOTECH AGPDF Download

Company Profile

Marinomed Biotech AG is a biopharmaceutical company, which engages in the development of therapies based on patent protected technology platforms. It operates through the Carragelose and Marinosolv segments. The Carragelose segment contains products with anti-viral properties target viral infections of the respiratory tract of different virus strains. The Marinosolv segment refers to the technology platform that increases the bioavailability of hardly soluble compounds for the treatment of sensitive tissues such as nose and eyes. The company was founded by Andreas Grassauer and Eva Prieschl-Grassauer in 2006 and is headquartered in Korneuburg, Austria.

Members of Management Board

Andreas GrassauerChairman of Managing Board
Cornelia KutzerMember of Executive Committee
Eva Prieschl-GrassauerMember of Executive Committee
Pascal SchmidtMember of Executive Committee

Board of directors

Simon Jules NebelChairman of Supervisory Board
Elisabeth LacknerMember of Supervisory Board
Gernot HoferMember of Supervisory Board
Brigitte EdererMember of Supervisory Board
Ulrich KinzelMember of Supervisory Board
Ute LassnigMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.